Clinical Trials
Closed
Phase
Accrual
95%
Published
SWOG Clinical Trial Number
S0618
Phase II Evaluation of E7389 (NSC-707389) in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
Research Committee(s)
Head and Neck Cancer
Activated
05-01-2006
Closed
01-01-2008
Closed
Phase
Accrual
40%
Published
SWOG Clinical Trial Number
S0429
A Pilot (Phase I) Study of Weekly Docetaxel and Cetuximab Chemoradiation for Poor Risk Stage III Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
04-01-2006
Closed
08-15-2009
Closed
Phase
Accrual
58%
Published
SWOG Clinical Trial Number
S0434
A Phase II Trial of BAY 43-9006 (Sorafenib) (NSC-724772) in Patients with Relapsing or Resistant Multiple Myeloma
Research Committee(s)
Myeloma
Activated
03-15-2006
Closed
Phase
Accrual
56%
Published
SWOG Clinical Trial Number
S0512
Phase II Trial of BAY 43-9006 (Sorafenib; NSC-724772) in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma
Research Committee(s)
Melanoma
Activated
03-15-2006
Closed
01-01-2009
ClinicalTrials.gov Registry Number
NCT00329641
Closed
Phase
Accrual
68%
Published
SWOG Clinical Trial Number
S0505
Phase II Trial of BAY 43-9006 (NSC #724772) in Advanced Soft Tissue Sarcomas
Research Committee(s)
Sarcoma
Activated
03-01-2006
Closed
Phase
Accrual
55%
Published
SWOG Clinical Trial Number
S0520
Phase II Study of PXD101 (NSC-726630) in Relapsed and Refractory Aggressive B-Cell Lymphomas
Research Committee(s)
Lymphoma
Activated
01-01-2006
Closed
05-01-2009
Closed
Phase
Accrual
2%
SWOG Clinical Trial Number
S0427
A Phase III Trial of Standard Fractionation Radiation and Concurrent Single Agent Cisplatin, with and without Docetaxel, Cisplatin, and 5-Fluorouracil Induction Chemotherapy, in Patients with Advanced Oropharyngeal Squamous Cell Cancer
Research Committee(s)
Head and Neck Cancer
Activated
12-15-2005
Closed
01-10-2007
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S0307
Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer
Research Committee(s)
Breast Cancer
Activated
11-15-2005
Closed
02-01-2010
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0433
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0509
A Phase II Study of Novel Oral Anti-Angiogenic Agent AZD2171 (NSC-732208) in Malignant Pleural Mesothelioma
Research Committee(s)
Lung Cancer
Activated
11-01-2005
Closed
04-01-2008
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S0410
Tandem Autologous Stem Cell Transplantation For Patients With Primary Progressive or Recurrent Hodgkin's Disease (A BMT Study), Phase II
Research Committee(s)
Lymphoma
Activated
10-15-2005
Closed
02-01-2009
Closed
Phase
Accrual
72%
Published
SWOG Clinical Trial Number
S0514
Phase II Study of BAY 43-9006 (NSC #724772) as Single Agent in Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
10-01-2005
Closed
01-01-2007
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S0424
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Research Committee(s)
Lung Cancer
Molecular Epidemiology
Activated
10-01-2005
Closed
03-15-2011
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
S0511
A Phase II Study of Goserelin Plus Anastrozole for the Treatment of Male Patients With Hormone-Receptor Positive Metastatic or Recurrent Breast Cancer"
Research Committee(s)
Breast Cancer
Activated
09-15-2005
Closed
01-10-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0350
Phase II Trial of Cisplatin Plus Etoposide Plus Gemcitabine Plus Solumedrol (PEGS) in Peripheral T-Cell Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
09-15-2005
Closed
12-01-2010
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
S0517
A Phase II Trial of Suberoylanilide Hydroxamic Acid (NSC-701852) for Recurrent or Primary Refractory Hodgkin's Lymphoma -
Research Committee(s)
Lymphoma
Activated
09-15-2005
Closed
08-01-2007
Closed
Phase
Accrual
19%
SWOG Clinical Trial Number
S0423
Phase II Trial of Pemetrexed for Advanced Chondrosarcomas
Research Committee(s)
Sarcoma
Activated
09-01-2005
Closed
01-15-2007
Closed
Phase
SWOG Clinical Trial Number
S0334
Cytogenetic and Fluorescence In Situ Hybridization Studies in Multiple Myeloma
Research Committee(s)
Myeloma
Activated
09-01-2005
Closed
06-15-2007
Closed
Phase
Accrual
53%
SWOG Clinical Trial Number
S0437
Prostate Cancer Prevention Trial (PCPT) Companion Long Term Follow Up Study for Men Diagnosed with Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Activated
09-01-2005
Closed
03-01-2009
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0430
Phase II Trial of Simple Oral Therapy (Continuous Oral Cyclophosphamide and Capecitabine) in Patients With Metastatic Breast Cancer
Research Committee(s)
Breast Cancer
Activated
08-15-2005
Closed
09-01-2007